Trial intelligence / Profile preview

Dexmedetomidine in Cataract Surgery Anesthesia

NCT05692167Phase 2Unknown

Sponsor
Kafrelsheikh University
Start
Jul 2023
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine in cataract, sponsored by Kafrelsheikh University. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

cataract

Beyond the preview

Go deeper on NCT05692167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05692167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call